HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Iversen Selected Research

ragaglitazar

1/2008Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists.
1/2005Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Iversen Research Topics

Disease

63Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 11/2003
16Inflammation (Inflammations)
01/2017 - 01/2005
14Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2022 - 06/2007
11Neoplasms (Cancer)
10/2022 - 06/2007
9Mycosis Fungoides
10/2022 - 01/2006
9Skin Diseases (Skin Disease)
08/2021 - 01/2005
6Allergic Contact Dermatitis
11/2013 - 10/2004
5Contact Dermatitis (Eczema, Contact)
11/2013 - 10/2004
3Necrosis
02/2021 - 01/2008
3Disease Progression
01/2021 - 08/2013
3Carcinogenesis
03/2016 - 01/2008
3Atopic Dermatitis (Atopic Eczema)
12/2014 - 08/2010
2Psoriatic Arthritis
07/2021 - 01/2021
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2021 - 01/2021
2Autoimmune Diseases (Autoimmune Disease)
01/2017 - 01/2017
2Myocardial Ischemia (Ischemic Heart Diseases)
06/2008 - 11/2005
2Heart Failure
06/2008 - 11/2005
1Pain (Aches)
04/2021
1Arthritis (Polyarthritis)
02/2021
1Axial Spondyloarthritis
01/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Hidradenitis Suppurativa
01/2021
1Pemphigus (Pemphigus Vulgaris)
01/2019
1Multiple Sclerosis
10/2018

Drug/Important Bio-Agent (IBA)

18CytokinesIBA
02/2021 - 01/2005
13Interleukin-17 (Interleukin 17)IBA
01/2022 - 07/2011
13Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2005
9MicroRNAs (MicroRNA)IBA
10/2022 - 12/2014
7Biological ProductsIBA
06/2021 - 01/2005
6Messenger RNA (mRNA)IBA
01/2021 - 01/2008
5Adalimumab (Humira)FDA Link
06/2021 - 12/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021 - 02/2006
5p38 Mitogen-Activated Protein KinasesIBA
05/2011 - 06/2007
5NF-kappa B (NF-kB)IBA
09/2007 - 11/2003
4Pharmaceutical PreparationsIBA
01/2022 - 01/2019
4Imiquimod (Aldara)FDA LinkGeneric
11/2020 - 10/2015
4Phosphotransferases (Kinase)IBA
01/2020 - 08/2007
4interleukin 20 (IL-20)IBA
01/2016 - 06/2007
4DNA (Deoxyribonucleic Acid)IBA
03/2014 - 01/2005
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2019
3Small Interfering RNA (siRNA)IBA
01/2018 - 10/2015
3Ustekinumab (CNTO 1275)FDA Link
10/2016 - 03/2013
3OxazoloneIBA
11/2013 - 04/2009
3NickelIBA
10/2011 - 10/2004
3CaspasesIBA
08/2009 - 12/2007
2brodalumabIBA
01/2022 - 11/2021
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 04/2017
2Enterotoxins (Enterotoxin)IBA
10/2021 - 07/2014
2Biomarkers (Surrogate Marker)IBA
08/2021 - 03/2013
2Biosimilar PharmaceuticalsIBA
06/2021 - 01/2021
2ixekizumabIBA
04/2021 - 11/2017
2ThioredoxinsIBA
01/2021 - 09/2020
2Prostaglandins AIBA
10/2020 - 10/2016
2Dimethyl FumarateIBA
01/2020 - 10/2018
2Peptides (Polypeptides)IBA
01/2020 - 11/2013
2Interleukin-8 (Interleukin 8)IBA
01/2018 - 01/2017
2AntibodiesIBA
01/2017 - 01/2016
2Etanercept (Enbrel)FDA Link
10/2016 - 12/2009
2Infliximab (Remicade)FDA Link
10/2016 - 12/2009
2Protein Kinases (Protein Kinase)IBA
01/2015 - 03/2011
2Antimicrobial PeptidesIBA
03/2014 - 07/2013
2ChemokinesIBA
10/2011 - 01/2005
2Protein Isoforms (Isoforms)IBA
05/2011 - 08/2010
2InflammasomesIBA
03/2011 - 11/2008
2Caspase 1 (ICE Protease)IBA
08/2009 - 12/2007
2ragaglitazarIBA
01/2008 - 01/2005
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2008 - 01/2005
1STAT5 Transcription FactorIBA
10/2021
1HLA-B Antigens (HLA-B)IBA
07/2021
1I-kappa B Proteins (I kappa B)IBA
04/2021
1ParaffinIBA
03/2021
1Formaldehyde (Formol)FDA Link
03/2021
1factor AIBA
02/2021
1InterleukinsIBA
02/2021
1vedolizumabIBA
02/2021
1Abatacept (Orencia)FDA Link
02/2021
1Interleukin-23 (Interleukin 23)IBA
01/2021
1Immunomodulating AgentsIBA
01/2021
1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
10/2020
1calcipotriene (calcipotriol)FDA LinkGeneric
10/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
09/2020
1secukinumabIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1apremilastIBA
12/2019
1RNA (Ribonucleic Acid)IBA
11/2019
1Circular RNAIBA
11/2019
1I-kappa B KinaseIBA
10/2019
1staphylococcal alpha-toxinIBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Prednisolone (Predate)FDA LinkGeneric
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019

Therapy/Procedure

13Therapeutics
01/2022 - 01/2005
4Aftercare (After-Treatment)
01/2020 - 01/2016
3Climatotherapy
01/2022 - 01/2019
3Drug Therapy (Chemotherapy)
01/2021 - 01/2010
2Intradermal Injections
11/2020 - 10/2015
2Biological Therapy
11/2017 - 10/2016
2Cardiac Rehabilitation
06/2008 - 11/2005
1Radiotherapy
01/2021